Y-mAbs

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Y-mAbs and other ETFs, options, and stocks.

About YMAB

Y-mAbs Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on the development and commercialization of antibody based therapeutic products for the treatment of cancer. Its services include discovery, protein engineering, clinical and regulatory.

CEO

Michael Rossi

CEOMichael Rossi

Employees

100

Employees100

Headquarters

New York, New York

HeadquartersNew York, New York

Founded

2015

Founded2015

Employees

100

Employees100

YMAB Key Statistics

Market cap

617.29M

Market cap617.29M

Price-Earnings ratio

-35.06

Price-Earnings ratio-35.06

Dividend yield

—

Dividend yield—

Average volume

266.64K

Average volume266.64K

High today

$17.06

High today$17.06

Low today

$13.00

Low today$13.00

Open price

$15.54

Open price$15.54

Volume

678.80K

Volume678.80K

52 Week high

$20.90

52 Week high$20.90

52 Week low

$4.60

52 Week low$4.60

YMAB News

Yahoo Finance 18h

Y-mAbs Therapeutics Reports Q1 2024 Results: Aligns with EPS Projections, Misses Revenue Estimates - Yahoo Finance

Revenue: Reported $19.93 million for Q1 2024, slightly below the estimate of $22.22 million. Net Loss: Posted a net loss of $6.63 million for Q1 2024, exceedin...

Yahoo Finance 18h

Y-mAbs Therapeutics, Inc. Reports Q1 Loss, Misses Revenue Estimates - Yahoo Finance

Y-mAbs Therapeutics, Inc. (YMAB) came out with a quarterly loss of $0.15 per share versus the Zacks Consensus Estimate of a loss of $0.12. This compares to loss...

Analyst ratings

71%

of 7 ratings

Buy

71.4%

Hold

14.3%

Sell